Siemens Healthineers: Berenberg reiterates 'buy' rating
(CercleFinance.com) - Berenberg has reiterated its "buy" recommendation and 42-euro target price on the Siemens Healthineers share following the medical equipment maker's second-quarter results.
In a note to clients, the German broker in particular notes that the group's imaging and advanced therapies businesses continue to outperform market expectations.
Berenberg says it remains confident in the group's story, and believes the current valuation still looks "reasonable."
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
In a note to clients, the German broker in particular notes that the group's imaging and advanced therapies businesses continue to outperform market expectations.
Berenberg says it remains confident in the group's story, and believes the current valuation still looks "reasonable."
Copyright (c) 2019 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.